Sam Brusco, Associate Editor07.06.22
Enovis has acquired orthopedic surgical guidance firm Insight Medical Systems, whose FDA-cleared ARVIS augmented reality (AR) solution is engineered for hip and knee replacement surgery.
The transaction’s financial details were not disclosed.
“We are excited to welcome Insight’s talented team to our Enovis family where we will work together to improve patient outcomes through the use of next generation augmented reality surgical guidance in orthopedic surgery,” Matt Trerotola, CEO of Enovis told the press. “Adding Insight’s technology to our rapidly growing Surgical business advances our enabling technologies platform with innovation tailored to today’s healthcare economics and especially the ASC.”
Enovis initially invested in Insight Medical Systems in 2020 and had a follow-on funding round in 2021. The ARVIS AR system then earned 510(k) clearance and successfully completed over 200 cases in the U.S.
“ARVIS delivers real-time, hands-free surgical guidance at the point of care and is designed to generate measurably better patient outcomes in a streamlined, space-conserving and cost-effective manner compared to traditional robotic offerings,” explained Brady Shirley, COO of Enovis. “Simply put, the ARVIS Augmented Reality System represents the next era of orthopedic technology, and we look forward to expanding its features and reach while integrating additional joint replacement surgery capabilities in the future.”
ARVIS will be commercially available in Q3 of this year and the Insight team will become part of the Enovis Surgical organization.
The transaction’s financial details were not disclosed.
“We are excited to welcome Insight’s talented team to our Enovis family where we will work together to improve patient outcomes through the use of next generation augmented reality surgical guidance in orthopedic surgery,” Matt Trerotola, CEO of Enovis told the press. “Adding Insight’s technology to our rapidly growing Surgical business advances our enabling technologies platform with innovation tailored to today’s healthcare economics and especially the ASC.”
Enovis initially invested in Insight Medical Systems in 2020 and had a follow-on funding round in 2021. The ARVIS AR system then earned 510(k) clearance and successfully completed over 200 cases in the U.S.
“ARVIS delivers real-time, hands-free surgical guidance at the point of care and is designed to generate measurably better patient outcomes in a streamlined, space-conserving and cost-effective manner compared to traditional robotic offerings,” explained Brady Shirley, COO of Enovis. “Simply put, the ARVIS Augmented Reality System represents the next era of orthopedic technology, and we look forward to expanding its features and reach while integrating additional joint replacement surgery capabilities in the future.”
ARVIS will be commercially available in Q3 of this year and the Insight team will become part of the Enovis Surgical organization.